PMID- 30016181 OWN - NLM STAT- MEDLINE DCOM- 20191017 LR - 20191017 IS - 1557-7465 (Electronic) IS - 1079-9907 (Linking) VI - 38 IP - 7 DP - 2018 Jul TI - Unfractionated Heparin Modulates Lipopolysaccharide-Induced Cytokine Production by Different Signaling Pathways in THP-1 Cells. PG - 283-289 LID - 10.1089/jir.2018.0042 [doi] AB - Sepsis is a complex syndrome resulting from the innate host response to infection. Apart from the well-known anticoagulant effects of heparin, it also possesses various immunomodulatory properties. Thus heparin seems to be a therapeutic drug in sepsis. We have demonstrated that unfractionated heparin (UFH) can inhibit lipopolysaccharide (LPS)-induced inflammatory responses in endothelial cells. The monocyte/macrophage system is a major contributor to host immunity and immune surveillance against infection. The aim of the study is to determine the inhibitory effect of UFH on cytokine production in THP-1 monocytes induced by LPS and to define the possible signaling pathways. The THP-1 cells were treated with UFH (0.1-10 U/mL) for 15 min before exposure to LPS (100 ng/mL). After 1 h, nuclear factor-kappaB (NF-kappaB) and phosphorylated inhibitor kappaB-alpha (IkappaB-alpha), c-Jun, c-fos, ERK1/2, JNK, and p38 mitogen-activated protein kinase (MAPK) expression levels were evaluated by Western blot. After 6 h, interleukin (IL)-1beta, tumor necrosis factor-alpha (TNF-alpha), IL-6, IL-8, and IL-18 protein concentrations were measured by enzyme-linked immunosorbent assay. Cell viability was determined by methyl thiazoyltetrazolium (MTT) assay. UFH inhibited LPS-induced phosphorylation of IkappaB-alpha, c-Jun, ERK1/2, JNK, and p38 MAPK but not c-fos. UFH also suppressed LPS-induced nuclear translocation of NF-kappaB. As expected, UFH decreased LPS-induced IL-1beta, TNF-alpha, IL-6, IL-8, and IL-18 protein levels, suggesting that UFH has an anti-inflammatory effect on THP-1 cells by interrupting the MAPK, NF-kappaB, and c-Jun signaling pathways. UFH could potentially contribute to treatments for sepsis. FAU - Li, Xu AU - Li X AD - Department of Intensive Care Unit, The First Affiliated Hospital, China Medical University , Shenyang, P.R. China . FAU - Zhao, Enfang AU - Zhao E AD - Department of Intensive Care Unit, The First Affiliated Hospital, China Medical University , Shenyang, P.R. China . FAU - Li, Lu AU - Li L AD - Department of Intensive Care Unit, The First Affiliated Hospital, China Medical University , Shenyang, P.R. China . FAU - Ma, Xiaochun AU - Ma X AD - Department of Intensive Care Unit, The First Affiliated Hospital, China Medical University , Shenyang, P.R. China . LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Interferon Cytokine Res JT - Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research JID - 9507088 RN - 0 (Anti-Inflammatory Agents, Non-Steroidal) RN - 0 (Cytokines) RN - 0 (Lipopolysaccharides) RN - 9005-49-6 (Heparin) SB - IM MH - Anti-Inflammatory Agents, Non-Steroidal/pharmacology MH - Cell Survival/drug effects MH - Cytokines/*biosynthesis/immunology MH - Heparin/*pharmacology MH - Humans MH - Lipopolysaccharides/*immunology MH - Sepsis/drug therapy/immunology MH - Signal Transduction/*drug effects MH - THP-1 Cells OTO - NOTNLM OT - THP-1 cells OT - cytokine OT - mitogen-activated protein kinase OT - nuclear factor-kappaB OT - unfractionated heparin EDAT- 2018/07/18 06:00 MHDA- 2019/10/18 06:00 CRDT- 2018/07/18 06:00 PHST- 2018/07/18 06:00 [entrez] PHST- 2018/07/18 06:00 [pubmed] PHST- 2019/10/18 06:00 [medline] AID - 10.1089/jir.2018.0042 [doi] PST - ppublish SO - J Interferon Cytokine Res. 2018 Jul;38(7):283-289. doi: 10.1089/jir.2018.0042.